CURLF – CURALEAF STOCK

Marijuana is set to be reclassified as a lower-risk drug in the United States which will have wide-reaching implications for the cannabis sector. The Biden administration in 2022 ordered the initiation of a review of how marijuana is scheduled within the Controlled Substances Act. The Drug Enforcement Administration (DEA), part of the Department of Justice […]

Marijuana is set to be reclassified as a lower-risk drug in the United States which will have wide-reaching implications for the cannabis sector. The Biden administration in 2022 ordered the initiation of a review of how marijuana is scheduled within the Controlled Substances Act. The Drug Enforcement Administration (DEA), part of the Department of Justice

Yesterday brought a significant rally for cannabis stocks as good news from Capitol Hill sent the entire sector into the green. The White House announced that plans to reschedule marijuana as a Schedule III substance are moving forward. This decision follows a recommendation from The Department of Justice (DOJ) that restrictions on cannabis be eased.

Tuesday’s announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies. But what does this mean in terms of actual numbers for the industry’s biggest players? To quantify the market cap added to the publicly traded market for some of the

Read More

Curaleaf Holdings, Inc. CURLF shares soared 24.6% in the last trading session to close at $6.28. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock’s 8% loss over the past four weeks. Shares of Curaleaf Holdings have increased steadily, courtsey of

Curaleaf Holdings, Inc. CURLF shares soared 24.6% in the last trading session to close at $6.28. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock’s 8% loss over the past four weeks. Shares of Curaleaf Holdings have increased steadily, courtsey of

Drug Enforcement Administration (DEA) officials have proposed reclassifying marijuana (or cannabis) as a Schedule Three drug. Despite a majority of states having legislation allowing for medicinal and recreational use, marijuana it still classified as a Schedule One narcotic along with heroin. Curaleaf (CURLF) CEO Matt Darin sits down with Catalysts Hosts Seana Smith and Madison

Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $6.40 and last traded at $6.28, with a volume of 3703682 shares. The stock had previously closed at $5.04. Wall Street Analysts Forecast Growth Separately, Needham & Company LLC

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well. The continued change in public opinion in favor of legalization might imply that it could have a chance of happening relatively soon